ALAUNOS THERAPEUTICS INC
(NASDAQ: TCRT)
Alaunos Therapeutics, Inc. is a biopharmaceutical company and clinical-stage oncology-focused cell therapy company, which engages in the development of adoptive TCR engineered T-cell therapies, or TCR-T, designed to treat multiple solid tumor types in large cancer patient populations with unmet clinical needs. Its pipeline includes Library TCR-T cell and mblL-15 TCR-T cell Therapy. The company was founded in 2003 and is headquartered in Houston, TX.
1.280
+0.010
(+0.79%)
Range
- - -
(-%)
Open
-
Previous Close
1.270
Bid Price
0.600
Bid Volume
18
Ask Price
0.625
Ask Volume
8
Volume
18,935
Value
-
Remark
View All Events
Loading Chart...
Please login to view stock data and analysis